Cite
HARVARD Citation
Imaji, M. et al. (2023). Safety and efficacy of osimertinib rechallenge or continuation after pneumonitis: A multicentre retrospective cohort study. European journal of cancer. pp. 15-24. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Imaji, M. et al. (2023). Safety and efficacy of osimertinib rechallenge or continuation after pneumonitis: A multicentre retrospective cohort study. European journal of cancer. pp. 15-24. [Online].